Shanghai Pharmaceuticals Holding Co Financial Overview
Shanghai Pharmaceuticals Holding Co's market cap is currently $76.51B. The company's EPS TTM is HK$0.9185789171999998; its P/E ratio is 6.98; and it has a dividend yield of 2.57%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Shanghai Pharmaceuticals Holding Co Earnings and Revenue History
